This study is designed to demonstrate the antipyretic effect of Indomethacin in common febrile conditions of childhood. It also compares the effect of this new anti-inflammatory agent with that of acetylsalicylic acid in a controlled man ner.
Get full access to this article
View all access options for this article.
References
1.
Bitka, P.J. et al.: Indomethacin: a new antirheumatic agent. Minnesota Med.47: 777, 1964.
2.
Hart, F.D. and Boardman, P.C.: Indomethacin: a new non-steroid anti-inflammatory agent. Brit. Med. J.5363: 965, 1963.
3.
Katz, A.M. et al.: A clinical trial of indomethacin in rheumatoid arthritis. Clin. Pharmacol. Ther.6: 25, 1965.
4.
Merck Sharp and Dohme Laboratories: Preliminary investigations of indomethacin—1963.
5.
Michotte, L.J. et al.: Clinical test of indomethacin. Acta Rheum. Scand.10: 273, 1964.
6.
Percy, J.S. et al.: Indomethacin in the treatment of rheumatic disease. Ann. Rheum. Dis.23: 226, 1964.
7.
Robinson, R.G. : Indomethacin in rheumatic disease. Med. J. Aust.1: 266, 1965.
8.
Wanka, J. et al.: Indomethacin in rheumatic diseases: a controlled clinical trial . Ann. Rheum. Dis.23: 218, 1964.
